OTCMKTS:PHGUF - Pharming Group Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $3.10
  • Forecasted Upside: 232.80 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.93
+0.30 (1.20%)

This chart shows the closing price for PHGUF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Pharming Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PHGUF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PHGUF

Analyst Price Target is $3.10
▲ +232.80% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Pharming Group in the last 3 months. The average price target is $3.10, with a high forecast of $3.10 and a low forecast of $3.10. The average price target represents a 232.80% upside from the last price of $0.93.

This chart shows the closing price for PHGUF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in Pharming Group.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/2/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/31/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/29/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/27/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/27/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/26/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/24/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/24/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/5/2021HC WainwrightReiterated RatingBuy$3.10
7/30/2020HC WainwrightReiterated RatingBuy
3/7/2018Roth CapitalReiterated RatingBuy
10/26/2017HC WainwrightReiterated RatingBuy
1/24/2017Roth CapitalReiterated RatingBuy
(Data available from 10/24/2016 forward)

News Sentiment Rating

0.04 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/28/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/27/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/27/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/26/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/26/2021
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/25/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/24/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
10/24/2021

Current Sentiment

  • 0 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Pharming Group logo
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The company offers RUCONEST which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.
Read More

Today's Range

Now: $0.93
Low: $0.93
High: $0.93

50 Day Range

MA: $0.98
Low: $0.90
High: $1.15

52 Week Range

Now: $0.93
Low: $0.86
High: $1.85

Volume

N/A

Average Volume

7,206 shs

Market Capitalization

$583.01 million

P/E Ratio

23.29

Dividend Yield

N/A

Beta

1.65

Frequently Asked Questions

What sell-side analysts currently cover shares of Pharming Group?

The following Wall Street research analysts have issued research reports on Pharming Group in the last twelve months: HC Wainwright, and Zacks Investment Research.
View the latest analyst ratings for PHGUF.

What is the current price target for Pharming Group?

1 Wall Street analysts have set twelve-month price targets for Pharming Group in the last year. Their average twelve-month price target is $3.10, suggesting a possible upside of 232.8%. HC Wainwright has the highest price target set, predicting PHGUF will reach $3.10 in the next twelve months. HC Wainwright has the lowest price target set, forecasting a price of $3.10 for Pharming Group in the next year.
View the latest price targets for PHGUF.

What is the current consensus analyst rating for Pharming Group?

Pharming Group currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PHGUF will outperform the market and that investors should add to their positions of Pharming Group.
View the latest ratings for PHGUF.

What other companies compete with Pharming Group?

Other companies that are similar to Pharming Group include Lonza Group, Imperial Brands, Turning Point Brands, Healthier Choices Management and Gilla.

How do I contact Pharming Group's investor relations team?

Pharming Group's physical mailing address is Darwinweg 24, Leiden P7, 2333 CR. The biotechnology company's listed phone number is (171) 524-7400 and its investor relations email address is [email protected] The official website for Pharming Group is www.pharming.com.